Synaptogenix Inc (SNPX NASDAQ) stock market data APIs
$2.3227
0.03(1.3%)
as of April 25, 2025
Synaptogenix Inc Financial Data Overview
Synaptogenix, Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing. The company was incorporated in 2012 and is headquartered in New York, New York.
Prev. Close
2.3227
Open
2.3553
High
2.3837
Low
2.2343
52 wk Range
1.84-5.38
Market Cap
3 231 K
Shares Outstanding
1 390 K
EPS
-4.1672
Beta
1.305
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Synaptogenix Inc data using free add-ons & libraries
Get Synaptogenix Inc Fundamental Data
Synaptogenix Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -6 805 152
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Synaptogenix Inc News
New
Orion Capital Management LLC Buys Qualcomm Inc, Distillate U.S. ...
Investment company Orion Capital Management LLC (Current Portfolio) buys Qualcomm Inc, Distillate U.S. Fundamental Stability & Value ETF, Palantir Technologies Inc, Vanguard Short-Term Inflation-Prote...
34 Stocks Moving In Monday's Mid-Day Session
Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare. Greenpro Capital Corp. (NAS...
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical studi...
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Marine Petroleum Trust (NASDAQ: MARPS) shares jumped 40.5% to $7.17 after gaining 8% on Monday. Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 20.8% to $9.17 amid an increase in the price of...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
